申请人:Jolidon Synese
公开号:US20050154000A1
公开(公告)日:2005-07-14
The present invention relates to compounds of formula
wherein
A—B, R
1
, R
2
,
R
3
, R
4
, and n are as defined herein; and to pharmaceutically acceptable salts thereof.
The compounds of formula I may be used in the treatment of neurological and neuropsychiatric disorders.
本发明涉及以下式的化合物
其中
A—B,R
1
,R
2
,
R
3
,R
4
和n如本文所定义;以及其药学上可接受的盐。
式I的化合物可用于治疗神经系统和神经精神疾病。